Investing Ideas
/
Swiss Pharmaceuticals & Biotech Sustainable Track Record

Swiss Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

1 companies

SKAN Group

Market Cap: CHF 1.5b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

New

SKAN

CHF 65.20

13.0%

-1.5%